Trial Profile
A Phase I, Open Label, Fixed Sequence, Single-Center Study to Evaluate the Effect of Multiple Dose Administration of VI-0521 on the Pharmacokinetics of a Single Dose of Oral Contraceptive in Healthy Female Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Dec 2021
Price :
$35
*
At a glance
- Drugs Phentermine/topiramate (Primary) ; Ethinylestradiol/norethisterone
- Indications Non-alcoholic steatohepatitis; Obesity; Sleep apnoea syndrome; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors VIVUS
- 09 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 09 Mar 2009 Additional lead trial centre identified as reported by ClinicalTrials.gov, last updated 9-Mar-2009.
- 09 Mar 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.